{"id":1754,"date":"2022-04-06T13:06:45","date_gmt":"2022-04-06T11:06:45","guid":{"rendered":"https:\/\/avextra.com\/?p=1754"},"modified":"2023-03-29T10:22:57","modified_gmt":"2023-03-29T08:22:57","slug":"neues-kapital-in-hoehe-von-44-mio-euro","status":"publish","type":"post","link":"https:\/\/avextra.com\/it\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/","title":{"rendered":"Neues Kapital in H\u00f6he von 4,4 Mio Euro"},"content":{"rendered":"\n<p><strong>Bensheim, 06. April 2022 \u2013 &nbsp;Eurox erh\u00e4lt bei Finanzierungsrunde \u00fcber 4 Millionen Euro f\u00fcr weiteres Wachstum &#8211; Neuer Investor Iberis Capital steigt ein [&#8230;]<\/strong><\/p>\n\n\n\n<p class=\"internal-link has-primary-color has-text-color\"><a href=\"https:\/\/www.presseportal.de\/pm\/161250\/5189899\" target=\"_blank\" rel=\"noreferrer noopener\">Weiterlesen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bensheim, 06. April 2022 \u2013 \u00a0Eurox erh\u00e4lt bei Finanzierungsrunde \u00fcber 4 Millionen Euro f\u00fcr weiteres Wachstum &#8211; Neuer Investor Iberis Capital steigt ein [&#8230;]<\/p>\n","protected":false},"author":1,"featured_media":2969,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"einzelbeitrag-ohne-bild","format":"standard","meta":{"inline_featured_image":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[8],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Neues Kapital in H\u00f6he von 4,4 Mio Euro - Cannabisbasierte Arzneimittel von Avextra<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/avextra.com\/it\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neues Kapital in H\u00f6he von 4,4 Mio Euro - Cannabisbasierte Arzneimittel von Avextra\" \/>\n<meta property=\"og:description\" content=\"Bensheim, 06. April 2022 \u2013 \u00a0Eurox erh\u00e4lt bei Finanzierungsrunde \u00fcber 4 Millionen Euro f\u00fcr weiteres Wachstum - Neuer Investor Iberis Capital steigt ein [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/avextra.com\/it\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/\" \/>\n<meta property=\"og:site_name\" content=\"Cannabisbasierte Arzneimittel von Avextra\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-06T11:06:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-29T08:22:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/avextra.com\/wp-content\/uploads\/2023\/03\/AVX_News-E-4mil.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"992\" \/>\n\t<meta property=\"og:image:height\" content=\"780\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"MHorn\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"MHorn\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/\"},\"author\":{\"name\":\"MHorn\",\"@id\":\"https:\/\/avextra.com\/#\/schema\/person\/7006cb73df866f43e6989b07577ecc43\"},\"headline\":\"Neues Kapital in H\u00f6he von 4,4 Mio Euro\",\"datePublished\":\"2022-04-06T11:06:45+00:00\",\"dateModified\":\"2023-03-29T08:22:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/\"},\"wordCount\":31,\"publisher\":{\"@id\":\"https:\/\/avextra.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/avextra.com\/wp-content\/uploads\/2023\/03\/AVX_News-E-4mil.jpg\",\"articleSection\":[\"deutsch\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/\",\"url\":\"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/\",\"name\":\"Neues Kapital in H\u00f6he von 4,4 Mio Euro - Cannabisbasierte Arzneimittel von Avextra\",\"isPartOf\":{\"@id\":\"https:\/\/avextra.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/avextra.com\/wp-content\/uploads\/2023\/03\/AVX_News-E-4mil.jpg\",\"datePublished\":\"2022-04-06T11:06:45+00:00\",\"dateModified\":\"2023-03-29T08:22:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/#primaryimage\",\"url\":\"https:\/\/avextra.com\/wp-content\/uploads\/2023\/03\/AVX_News-E-4mil.jpg\",\"contentUrl\":\"https:\/\/avextra.com\/wp-content\/uploads\/2023\/03\/AVX_News-E-4mil.jpg\",\"width\":992,\"height\":780},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/avextra.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neues Kapital in H\u00f6he von 4,4 Mio Euro\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/avextra.com\/#website\",\"url\":\"https:\/\/avextra.com\/\",\"name\":\"Cannabisbasierte Arzneimittel von Avextra\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/avextra.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/avextra.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/avextra.com\/#organization\",\"name\":\"Avextra Pharma GmbH\",\"url\":\"https:\/\/avextra.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/avextra.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/avextra.com\/wp-content\/uploads\/2022\/08\/AVX-Logo_Wortmarke-Balken_extrablue.svg\",\"contentUrl\":\"https:\/\/avextra.com\/wp-content\/uploads\/2022\/08\/AVX-Logo_Wortmarke-Balken_extrablue.svg\",\"caption\":\"Avextra Pharma GmbH\"},\"image\":{\"@id\":\"https:\/\/avextra.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/avextra-ag\/\",\"https:\/\/www.xing.com\/pages\/avextra\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/avextra.com\/#\/schema\/person\/7006cb73df866f43e6989b07577ecc43\",\"name\":\"MHorn\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/avextra.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/446d07f04c2eb204a64dbbc0313e10c7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/446d07f04c2eb204a64dbbc0313e10c7?s=96&d=mm&r=g\",\"caption\":\"MHorn\"},\"sameAs\":[\"https:\/\/dev.studio-horn.de\/staging\/avextra\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neues Kapital in H\u00f6he von 4,4 Mio Euro - Cannabisbasierte Arzneimittel von Avextra","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/avextra.com\/it\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/","og_locale":"it_IT","og_type":"article","og_title":"Neues Kapital in H\u00f6he von 4,4 Mio Euro - Cannabisbasierte Arzneimittel von Avextra","og_description":"Bensheim, 06. April 2022 \u2013 \u00a0Eurox erh\u00e4lt bei Finanzierungsrunde \u00fcber 4 Millionen Euro f\u00fcr weiteres Wachstum - Neuer Investor Iberis Capital steigt ein [...]","og_url":"https:\/\/avextra.com\/it\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/","og_site_name":"Cannabisbasierte Arzneimittel von Avextra","article_published_time":"2022-04-06T11:06:45+00:00","article_modified_time":"2023-03-29T08:22:57+00:00","og_image":[{"width":992,"height":780,"url":"https:\/\/avextra.com\/wp-content\/uploads\/2023\/03\/AVX_News-E-4mil.jpg","type":"image\/jpeg"}],"author":"MHorn","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"MHorn","Tempo di lettura stimato":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/#article","isPartOf":{"@id":"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/"},"author":{"name":"MHorn","@id":"https:\/\/avextra.com\/#\/schema\/person\/7006cb73df866f43e6989b07577ecc43"},"headline":"Neues Kapital in H\u00f6he von 4,4 Mio Euro","datePublished":"2022-04-06T11:06:45+00:00","dateModified":"2023-03-29T08:22:57+00:00","mainEntityOfPage":{"@id":"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/"},"wordCount":31,"publisher":{"@id":"https:\/\/avextra.com\/#organization"},"image":{"@id":"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/#primaryimage"},"thumbnailUrl":"https:\/\/avextra.com\/wp-content\/uploads\/2023\/03\/AVX_News-E-4mil.jpg","articleSection":["deutsch"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/","url":"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/","name":"Neues Kapital in H\u00f6he von 4,4 Mio Euro - Cannabisbasierte Arzneimittel von Avextra","isPartOf":{"@id":"https:\/\/avextra.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/#primaryimage"},"image":{"@id":"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/#primaryimage"},"thumbnailUrl":"https:\/\/avextra.com\/wp-content\/uploads\/2023\/03\/AVX_News-E-4mil.jpg","datePublished":"2022-04-06T11:06:45+00:00","dateModified":"2023-03-29T08:22:57+00:00","breadcrumb":{"@id":"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/#primaryimage","url":"https:\/\/avextra.com\/wp-content\/uploads\/2023\/03\/AVX_News-E-4mil.jpg","contentUrl":"https:\/\/avextra.com\/wp-content\/uploads\/2023\/03\/AVX_News-E-4mil.jpg","width":992,"height":780},{"@type":"BreadcrumbList","@id":"https:\/\/avextra.com\/2022\/04\/neues-kapital-in-hoehe-von-44-mio-euro\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/avextra.com\/"},{"@type":"ListItem","position":2,"name":"Neues Kapital in H\u00f6he von 4,4 Mio Euro"}]},{"@type":"WebSite","@id":"https:\/\/avextra.com\/#website","url":"https:\/\/avextra.com\/","name":"Cannabisbasierte Arzneimittel von Avextra","description":"","publisher":{"@id":"https:\/\/avextra.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/avextra.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/avextra.com\/#organization","name":"Avextra Pharma GmbH","url":"https:\/\/avextra.com\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/avextra.com\/#\/schema\/logo\/image\/","url":"https:\/\/avextra.com\/wp-content\/uploads\/2022\/08\/AVX-Logo_Wortmarke-Balken_extrablue.svg","contentUrl":"https:\/\/avextra.com\/wp-content\/uploads\/2022\/08\/AVX-Logo_Wortmarke-Balken_extrablue.svg","caption":"Avextra Pharma GmbH"},"image":{"@id":"https:\/\/avextra.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/avextra-ag\/","https:\/\/www.xing.com\/pages\/avextra"]},{"@type":"Person","@id":"https:\/\/avextra.com\/#\/schema\/person\/7006cb73df866f43e6989b07577ecc43","name":"MHorn","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/avextra.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/446d07f04c2eb204a64dbbc0313e10c7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/446d07f04c2eb204a64dbbc0313e10c7?s=96&d=mm&r=g","caption":"MHorn"},"sameAs":["https:\/\/dev.studio-horn.de\/staging\/avextra"]}]}},"author_meta":{"display_name":"MHorn","author_link":"https:\/\/avextra.com\/it\/author\/mhorn\/"},"featured_img":"https:\/\/avextra.com\/wp-content\/uploads\/2023\/03\/AVX_News-E-4mil-300x236.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/avextra.com\/it\/category\/deutsch\/\" class=\"advgb-post-tax-term\">deutsch<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">deutsch<\/span>"]}},"comment_count":0,"relative_dates":{"created":"Pubblicato 4 anni fa","modified":"Aggiornato 3 anni fa"},"absolute_dates":{"created":"Pubblicato il 6. Aprile 2022","modified":"Aggiornato il 29. Marzo 2023"},"absolute_dates_time":{"created":"Pubblicato il 6. Aprile 2022 13:06","modified":"Aggiornato il 29. Marzo 2023 10:22"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/avextra.com\/it\/wp-json\/wp\/v2\/posts\/1754"}],"collection":[{"href":"https:\/\/avextra.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avextra.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avextra.com\/it\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/avextra.com\/it\/wp-json\/wp\/v2\/comments?post=1754"}],"version-history":[{"count":1,"href":"https:\/\/avextra.com\/it\/wp-json\/wp\/v2\/posts\/1754\/revisions"}],"predecessor-version":[{"id":2985,"href":"https:\/\/avextra.com\/it\/wp-json\/wp\/v2\/posts\/1754\/revisions\/2985"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/avextra.com\/it\/wp-json\/wp\/v2\/media\/2969"}],"wp:attachment":[{"href":"https:\/\/avextra.com\/it\/wp-json\/wp\/v2\/media?parent=1754"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avextra.com\/it\/wp-json\/wp\/v2\/categories?post=1754"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avextra.com\/it\/wp-json\/wp\/v2\/tags?post=1754"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}